Genfit(GNFT)

Search documents
Genfit (GNFT) Investor Presentation - Slideshow
2022-04-08 17:18
Corporate Presentation April 2022 Disclaimer & Looking Forward Statement IMPORTANT NOTICE – YOU MUST READ THE FOLLOWING BEFORE CONTINUING. THIS PRESENTATION HAS BEEN PREPARED BY GENFIT AND IS FOR INFORMATION PURPOSES ONLY. CERTAIN OF THE INFORMATION CONTAINED HEREIN CONCERNING ECONOMIC TRENDS AND PERFORMANCE IS BASED UPON OR DERIVED FROM INFORMATION PROVIDED BY THIRD-PARTY CONSULTANTS AND OTHER INDUSTRY SOURCES. WHILE GENFIT BELIEVES THAT SUCH INFORMATION IS ACCURATE AND THAT THE SOURCES FROM WHICH IT HAS B ...
Genfit(GNFT) - 2021 Q4 - Earnings Call Transcript
2022-04-08 14:24
Genfit SA (NASDAQ:GNFT) Q4 2021 Earnings Conference Call April 8, 2022 8:00 AM ET Company Participants Stefanie Magner - Deputy Director, Legal Affairs Pascal Prigent - Chief Executive Officer Tom Baetz - Chief Financial Officer Dean Hum - Chief Scientific Officer Carol Addy - Chief Medical Officer Conference Call Participants Thomas Smith - SVB Leerink Arsene Guekam - Kepler Cheuvreux Ed Arce - H.C. Wainwright Operator Good day, and welcome to the Genfit's Full-Year 2021 Financial Results and Corporate Upd ...
Genfit(GNFT) - 2020 Q4 - Annual Report
2021-04-23 15:54
| | | Page | | --- | --- | --- | | PART I | | 9 | | Item 1. | Identity of Director, Senior Management and Advisers | 9 | | Item 2. | Offer Statistics and Expected Timetable | 9 | | Item 3. | Key Information | 9 | | Item 4. | Information on the Company | 57 | | Item 5. | Operating and Financial Review and Prospects | 98 | | Item 6. | Directors, Senior Management and Employees | 116 | | Item 7. | Major Shareholders and Related Party Transactions | 138 | | Item 8. | Financial Information | 142 | | Item 9. | Th ...
Genfit(GNFT) - 2020 Q2 - Earnings Call Transcript
2020-10-01 01:49
GENFIT SA (NASDAQ:GNFT) Q2 2020 Results Conference Call September 30, 2020 4:30 PM ET Company Participants Stefanie Magner - Deputy Director, Legal Affairs Pascal Prigent - CEO Dean Hum - Chief Scientific Officer and COO Conference Call Participants Thomas Smith - SVB Leerink Derek Archila - Stifel Thomas Yip - H.C. Wainwright Operator Greetings and welcome to the GENFIT Half Year 2020 Financial Report and New Corporate Strategy Conference Call. At this time, all participants are in a listen-only mode. A qu ...
Genfit (GNFT) Investor Presentation - Slideshow
2020-08-31 17:44
June 19, 2020 2020 CORPORATE PRESENTATION 2020 Disclaimer & Forward Looking Statements IMPORTANT NOTICE – YOU MUST READ THE FOLLOWING BEFORE CONTINUING. THIS PRESENTATION HAS BEEN PREPARED BY GENFIT AND IS FOR INFORMATION PURPOSES ONLY. CERTAIN OF THE INFORMATION CONTAINED HEREIN CONCERNING ECONOMIC TRENDS AND PERFORMANCE IS BASED UPON OR DERIVED FROM INFORMATION PROVIDED BY THIRD-PARTY CONSULTANTS AND OTHER INDUSTRY SOURCES. WHILE GENFIT BELIEVES THAT SUCH INFORMATION IS ACCURATE AND THAT THE SOURCES FROM ...
Genfit(GNFT) - 2019 Q4 - Annual Report
2020-05-27 16:35
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission File Number 001-38844 GENFIT S.A. (Exact name of Registrant as specified in its charter and translation of Registrant's name into English) FRANCE FORM 20-F ☐ REGISTRATION ST ...